 

1

ADDENDA:
Addendum

lmmunohistochemical stains demonstrate that the tumor is strongly positive for cytokeratin 7 and negative for
cytakeratin 2G. Thgse findings are conaistent with tha lung tumor lasing a primary lunmaion and not metastatic disease.

 

FINAL DIAGNOSIS:

PART 1: LYMPH NUDE, SUBCARINAL, EXCISION —
BENIGN LYMPH NUDE, NEGATIVE FOR METASTATIC ADENOCARCINOMA.

PART 2: LYMPH NODE, LEFT TRACHEAL-BRONGHIAL, EXCISION -
LYMPH NODE, NEGATIVE FOR METASTATIC ADENOCARCINOMA.

PART 3: LYMPH NODE, TRACHEAL-BRONCHIAL, RIGHT. EXCISION m
LYMPH NODE, NEGATIVE FOR META8TATIC ADENOCARCINOMA.

PART 4: LUNG, RIGHT UPPER LOBE, BIOPSY OF MASS m
POSITIVE FOR NON-SMALL CELL CARCINOMA.

PART 5: LYMPH NODE, TRACHEALuBRONCHIAL, EXCISION -
POSITIVE FOR METASTATIC ADENOCARCINOMA.

PART 6: LUNG, RIGHT, PNEUMONECTOMY m

MODERATELY DIFFERENTIATED ADENOCARCINOMA, 3.9 CM, IN PART CLEAR-CELL TYPE.
TUMOR FOCALLY INVADES VISCERAL PLEURA BUT DOES NOT PENETRATE IT.
ANGIOLYMPHATIC INVA$ION IDENTIFIED.

SIX 0F" TWENTY-FIVE (6125} LYMPH MODES POSITIVE FOR METASTATIC ADENOCARCINOMA.
NO PERINEURAL INVASION IDENTIFIED. ‘
SURGICAL MARGINS OF RESECTION ARE FREE or TUMOR.

PATHOLUGIC STAGE T2, N1, MX (see comment).

EMPHYSEMATOUS CHANGES.

SMOKER‘S BRONCHIOLITIS.

TFQWFIPQPP

PART 7: LYMPH NODE. MAIN PA, EXCISION —
LYMPH NODE, NEGATIVE FOR METASTATIC ADENOCARCINOMA.

PART B: LYMPH NODE, MAIN PA, EXCISION —
LYMPH NODE, NEGATIVE FOR METASTATIC ADENOCARCINOMA.

PART 9: LYMPH NODE, HILAR REGION. EXCISION w»
LYMPH NODE, NEGATIVE FOR METASTATIC ADENOCARCINOMA.

PART 10: LYMF’H NODE. LEVEL 12, EXCISION m
LYMPH NODE, NEGATIVE FOR META$TATIC ADENOCARCINOMA.

PART 11: LYMPH NODE, SUBCARINAL REGION, EXCISION --
I LYMPH NODE, NEGATIVE FOR METASTATIC ADENOCARCINOMA.

COMMENT:

Within the submitted tiﬁsue, there is a 3.9 cm, moderately differentiated adenocarcinoma which in part is of clear-cell
typei Based on the solitary nature of the neoplasm. we favor it being a primary lung tumor, however,
immunohistochemicai stains are being performed to rule out the possibility of metastatic disease. In total, seven lymph
nodes are positive for metastatic carcinoma, six of them; being from the hllus and one being a tracheal-bronchial lymph
node. Since we are unsure what Ievei the tracheal-bronchial lymph comes from, the pathologic stage is T2, N1, MX.
Re5u|ts of immunohistochemical stains will be reported in a separate addendum.

SYNOPTIC .. PRIMARY LUNG TUMORS

w

A. Location; g
1. RUL. 3. RLL
2. RML 4. LLL
B. Procedure: 5;
1. Wedge/Segmental 3. Bilohocwmy

2. Loboctomy 4. Pneumonectomy
C. Size of tumor (maximum dimension): 31.33 cm.
D. Satellite nodules: g
1. yes
E. Type: 3
1. lnvanivo squamous carcinoma
2. Basaloicl squamous carcinoma

3t Invasive adonocarcinoma

4. Bronchioloalveolar carcinoma. nonmucinous type
5. Bronchloloalveolar carcinoma, muc‘mous type

6. Largo cell carcinoma

7’. Clear cell carcinoma

8. Giant cell carcinoma

9. Sarcomatold carcinoma

2. no

10. Blastoma
F. Architectural grade: 2
1. well 2. moderate
G. Nuclear grade: g 3.
1. Low 2. Intermediate
H. Central vs. peripheral origin; Not applicable
1. yes 2. no
I. Visceral pleural invasion through elastica: fl
1. yes 2. no '
J. Parietal pleural Invasion: 2;
1. yes 2. no
K. Chest wall invasion (into skeletal muscle or soft tissue): g
1. yes 2. no
L... Angiolymphatic invasion: 1
1. yes 2. no
M. Necrosis: l
1. £50% 2. 260%.
N. Surgical margins involved: _2_
1. yes 2. no I
O. Inflammatory (desmoplastic) reaction: 1
1. mild 2. moderate
P. Hilar lymph node involvement: 1
1. yes 2. no,

 

5. LLJL.
6. Bronchua intermedlus

11. Fetal type adenocarcinoma

12. Small cell carcinoma

13. Carcinoid

14. Atypical carcinoid

T5. Sarcoma

16. Adenooquamous carcinoma

17. Mixed non-small cell carcinoma. N03
18. Carcinosarcoma

19. Other

3. poor/undifferentiated

Q. If hilar lymph nodes involved. 6 positive / 25 examined = g I' 25;

R. Modiaslinol nodes involved: 1_

1. yes 2. no

8. Mediaslinalinode grooms) involved: 3
1. Level 4R 4. Level i’Ft
2. Level 5R 5. Level 9R
3. Level 6R 6. Level 10R

T. Underlying diseasels); 1/4w
1. Emphysema
2. Bronchlectasis
3. Tumorlots
U. TNM Stage: ”lg

4. Smokers bronchiolilis
5. Asthma
6. Paronchymal scar

N1 M§

3. High
3. severe
3. not applicable
7. Level 4L 10. Level '71,
8. Level 5L. 11. Level 9L
9. Level 6L 12.‘Levol 10L

”7. Pneumoconlooio, NOS
8. Chronic interstitial pneumoma

